Area of research
Hematology · Immunology
Research interest
Research focused on Multiple myeloma and Carcinoembryonic antigen, with related work in Monoclonal gammopathy of undetermined significance, Cancer research, Cell adhesion molecule. Notable publications include 'Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug...', 'Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6', and 'Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1'.
Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling
Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
Asymptomatic Multiple Myeloma – Molecular Background of Progression and Prognosis
Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis
Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
The Glycome of Normal and Malignant Plasma Cells
Expression Quantitative Trait Loci Reveal Regulatory Regions Important In The Pathogenesis of Multiple Myeloma
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma
1101 Human Tumor Cells Inhibit T Cell Responses Through Expression of Carcinoembryonic-antigen-related Cell Adhesion Molecule-6 (CEACAM-6)
Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.